Research, harm reduction, and community insights on psilocybin, psychedelic wellness, and the evolving legal landscape.
Industry news: All posts·2026 therapy trends·Therapy cost·Common mistakes
Legal access: Legal updates·State legal status·Oregon vs Colorado access
Compare therapies: Psilocybin vs ketamine·Psilocybin vs MDMA vs ketamine·Medication screening·SSRIs·Lithium
From COMP360's Phase 3 milestone to Colorado's rapid scale-up and MDMA's FDA resubmission, these are the five psychedelic therapy developments worth tracking in 2026.
Legal psilocybin therapy in Oregon or Colorado costs $1,500–$3,500 per complete experience. Retreats abroad run $3,000–$8,000+. Here's exactly what drives cost, what's included, and how to reduce it.
Most problems in psilocybin therapy are preventable. Here are the seven most common mistakes — stopping SSRIs abruptly, skipping integration, choosing an unverified facilitator — and exactly what to do instead.
From sub-perceptual microdoses to high-dose sessions, dose strongly shapes outcomes. We break down the evidence by dose range and what it means for therapy and personal use.
Early studies suggest that auditory stimulation and psilocybin may each influence brain rhythms and plasticity. We look at what's known and what's speculative in the context of Alzheimer's and cognitive decline.
Researchers find significant and lasting reductions in depression symptoms after just two guided psilocybin sessions.
As legal access expands, advocates push for insurance coverage. Here's where the conversation stands in 2026.